Research Peptide

LL-37 5mg

Human cathelicidin antimicrobial peptide — 37 amino acids from the hCAP-18 C-terminal domain The only cathelicidin-derived antimicrobial peptide identified in humans Research-grade · CAS 154947-66-7 For in vitro antimicrobial and innate immunity research only

$59.99 In stock
Research-Grade CompoundsManufactured to research-grade standards for laboratory research use only.
Discreet ShippingEvery order ships in plain, protective packaging.
In-House FulfillmentOrders are inspected, packed, and shipped directly by the Heritage Labs team.
Same-day dispatch on orders before 12:00 PM ET, Mon–Fri. Discreet, plain packaging.
In-House Fulfillment Orders are inspected, packed, and shipped directly by the Heritage Labs team.
View this compound’s Certificate of Analysis →
SSL 256-bit Secure Checkout

For laboratory research use only. Not for human or veterinary consumption. SKU 375.

Overview

Product details.

LL-37 5mg — Human Cathelicidin
Humans have exactly one cathelicidin-derived antimicrobial peptide. This is it. LL-37 is the 37-amino-acid C-terminal fragment of hCAP-18 (human Cationic Antimicrobial Protein-18), and it turns out to be far more than just an antibiotic — it is a chemotactic agent, a TLR modulator, an angiogenesis pathway participant, and a biofilm disruptor. The research literature on LL-37 spans innate immunity, host defense, wound healing, and antimicrobial resistance.
Research-Grade Compounds
Manufactured to research-grade standards for laboratory research use only.
Discreet Shipping
Every order ships in plain, protective packaging.
In-House Fulfillment
Orders are inspected, packed, and shipped directly by the Heritage Labs team.

Specifications

Amino Acids 37
Parent Protein hCAP-18
Molecular Formula C205H340N60O53
Molecular Weight 4493.33 g/mol
CAS Number 154947-66-7
Structure Amphipathic alpha-helix
Form Lyophilized powder
Quantity 5mg per vial

Mechanism of action

The amphipathic alpha-helical structure is the key. One face of the helix is hydrophobic, the other hydrophilic. This lets LL-37 interact with the negatively charged phospholipids in bacterial membranes, leading to permeabilization. MIC studies have characterized activity against panels of gram-positive and gram-negative organisms. But the antimicrobial activity is only part of the story.

Beyond killing bacteria

Published research documents LL-37 as a chemotactic agent that recruits neutrophils, monocytes, and T cells through FPRL1 receptor interactions. It modulates TLR4 inflammatory signaling. It participates in VEGF-mediated angiogenesis and EGFR transactivation in epithelial models. And at sub-MIC concentrations, it disrupts bacterial biofilms by interfering with matrix components and quorum sensing.

Frequently paired with

Quality and testing

Every Heritage Labs compound is manufactured to research-grade standards and shipped in protective packaging.

Storage

  • Lyophilized: -20°C
  • Reconstituted: 2-8°C, use within 30 days

For laboratory research use only. Not for human or veterinary use.

For laboratory research use only. Not for human or veterinary use. This product is not a drug or supplement and is not intended to diagnose, treat, cure, or prevent any disease.
FDA DISCLAIMER: All products are intended for research use only as defined by the FDA. Not for use in diagnostic procedures, human use, or veterinary use. Products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. All products sold by Heritage Labs are intended strictly for laboratory research, analytical, or in-vitro purposes only. Heritage Labs operates as a chemical supplier and is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act. Additionally, Heritage Labs is not classified as an outsourcing facility under Section 503B of the same Act. The statements on this website have not been evaluated by the U.S. Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease.
Loading...